Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

miR-378f targets CAB39 to regulate autophagy in chemotherapy-induced peripheral neuropathy.

Created on 23 Oct 2026

Authors

Yeeun Kim, Myeongguk Jeong, Hyeokjin Kwon, Jungho Kim, Yeongdon Ju, Do-Young Kang, Aelee Jang, Go-Eun Choi

Published in

Frontiers in molecular neuroscience. Volume 19. Pages 1958322. Epub Oct 07, 2026.

Abstract

Chemotherapy is the most common cancer therapy due to its ability to effectively destroy cancer cells. However, peripheral neuropathy is a notable side effect, which has no clearly established prevention or treatment methods. Although various therapeutic strategies using microRNAs (miRNAs) have been developed for a wide range of diseases, the role of miRNAs in neuroregeneration has yet to be elucidated. Our group previously identified five differentially expressed miRNAs in the plasma of patients with gastric cancer receiving XELOX (capecitabine and oxaliplatin) chemotherapy. Among these, miR-378f alone showed a significant correlation with peripheral neuropathy severity, providing the rationale for the present study. Bioinformatic analysis further predicted calcium-binding protein 39 (CAB39), a regulator of autophagy, as a shared target of these miRNAs. The downregulation of miR-378f increased CAB39 expression, activated AMPK and inhibited mTOR. Furthermore, changes in autophagy-related markers were observed, including increased Beclin-1 expression, elevated LC3-I to LC3-II conversion, and decreased p62 expression. The findings of the present study suggest that autophagy regulation by miR-378f may be a novel diagnostic and therapeutic target for peripheral neuropathy.

PMID:
42908948
Bibliographic data and abstract were imported from PubMed on 23 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 18
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement